omniture
logo
Search
LUNIT INC
Media Room

Photo News

rss
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

2024-05-20 21:00 3163
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

2024-04-08 21:00 2869
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

2024-04-01 21:00 3063
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

2024-03-26 21:00 2301
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

2024-03-18 21:00 3018
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

2024-03-14 21:00 2802
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

2024-02-28 22:03 2434
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

2024-02-16 22:03 6168
Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

2024-01-17 22:15 2963
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

2024-01-16 22:04 3130
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

2023-12-14 22:05 2526
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

2023-12-11 22:30 2752
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

2023-11-30 22:10 3268
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology

AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology

2023-11-27 22:05 2483
Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

2023-11-22 22:07 3005
Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

2023-11-16 22:00 2712
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

2023-11-14 22:00 3109
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

2023-11-13 22:00 2427
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

2023-11-06 21:00 2422
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023

AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023

2023-11-01 21:08 2786
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

2023-10-27 21:07 4049
12345